China NMPA Drug Inspection - Xi"an Lantai Pharmaceutical Co., Ltd. - Lemai Dispersible Tablets
China NMPA drug inspection for Xi"an Lantai Pharmaceutical Co., Ltd. published December 28, 2020. Drug: Lemai Dispersible Tablets. The Shaanxi Provincial Drug Administration released its 12th Drug Quality Bulletin of 2020 on December 28, 2020, followi
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Xi"an Lantai Pharmaceutical Co., Ltd. published December 28, 2020. Drug: Lemai Dispersible Tablets. The Shaanxi Provincial Drug Administration released its 12th Drug Quality Bulletin of 2020 on December 28, 2020, followi
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox